» Articles » PMID: 18218322

IL-23 and IL-17 in Tuberculosis

Overview
Journal Cytokine
Date 2008 Jan 26
PMID 18218322
Citations 137
Authors
Affiliations
Soon will be listed here.
Abstract

Tuberculosis is a chronic disease requiring the constant expression of cellular immunity to limit bacterial growth. The constant expression of immunity also results in chronic inflammation, which requires regulation. While IFN-gamma-producing CD4+ T helper cells (Th1) are required for control of bacterial growth they also initiate and maintain a mononuclear inflammatory response. Other T cell subsets are induced by Mycobacterium tuberculosis (Mtb) infection including those able to produce IL-17 (Th17). IL-17 is a potent inflammatory cytokine capable of inducing chemokine expression and recruitment of cells to parenchymal tissue. Both the IL-17 and the Th17 response to Mtb are largely dependent upon IL-23. Although both Th17 and Th1 cells are induced following primary infection with Mtb, the protective response is significantly altered in the absence of Th1 cells but not in the absence of Th17. In contrast, in vaccinated animals the absence of memory Th17 cells results in loss of both the accelerated memory Th1 response and protection. Th1 and Th17 responses cross-regulate each other during mycobacterial infection and this may be important for immunopathologic consequences not only in tuberculosis but also other mycobacterial infections.

Citing Articles

The importance of inflammatory biomarkers in detecting and managing latent tuberculosis infection.

Gunasekaran H, Ranganathan U, Bethunaickan R Front Immunol. 2025; 16:1538127.

PMID: 39981231 PMC: 11839662. DOI: 10.3389/fimmu.2025.1538127.


Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents.

Picchianti-Diamanti A, Aiello A, De Lorenzo C, Migliori G, Goletti D Front Immunol. 2025; 16:1494283.

PMID: 39963138 PMC: 11830708. DOI: 10.3389/fimmu.2025.1494283.


The Importance of Lung Innate Immunity During Health and Disease.

Ryanto G, Suraya R, Nagano T Pathogens. 2025; 14(1).

PMID: 39861052 PMC: 11768135. DOI: 10.3390/pathogens14010091.


How Do ROS Induce NETosis? Oxidative DNA Damage, DNA Repair, and Chromatin Decondensation.

Azzouz D, Palaniyar N Biomolecules. 2024; 14(10).

PMID: 39456240 PMC: 11505619. DOI: 10.3390/biom14101307.


Depletion of essential mycobacterial gene glmM reduces pathogen survival and induces host-protective immune responses against tuberculosis.

Agarwal M, Bhaskar A, Singha B, Mukhopadhyay S, Pahuja I, Singh A Commun Biol. 2024; 7(1):949.

PMID: 39107377 PMC: 11303689. DOI: 10.1038/s42003-024-06620-9.


References
1.
Colditz G, Brewer T, Berkey C, Wilson M, Burdick E, Fineberg H . Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. 1994; 271(9):698-702. View

2.
Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24(2):179-89. DOI: 10.1016/j.immuni.2006.01.001. View

3.
Turner J, Dobos K, Keen M, Frank A, Ehlers S, Orme I . A limited antigen-specific cellular response is sufficient for the early control of Mycobacterium tuberculosis in the lung but is insufficient for long-term survival. Infect Immun. 2004; 72(7):3759-68. PMC: 427451. DOI: 10.1128/IAI.72.7.3759-3768.2004. View

4.
Dragon S, Saffar A, Shan L, Gounni A . IL-17 attenuates the anti-apoptotic effects of GM-CSF in human neutrophils. Mol Immunol. 2007; 45(1):160-8. DOI: 10.1016/j.molimm.2007.04.027. View

5.
Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J . Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol. 2006; 18(6):347-61. DOI: 10.1016/j.smim.2006.07.010. View